KIR3DL1 and viral infectious disease: However, the down‐regulation of major histocompatibility complex (MHC) class I molecules that often follows viral infection or cellular transformation alleviates NK cell inhibition via KIR3DL1, leading to proinflammatory cytokine release and cytolytic activity.